Found: 3
Select item for more details and to access through your institution.
OA03 Are there any differences in the outcomes of treatment of a 12-month course of rituximab BCD020 biosimilar in systemic lupus erythematosus in children with early and late administration of the drug.
- Published in:
- Rheumatology, 2023, v. 62, p. 1, doi. 10.1093/rheumatology/kead323.003
- By:
- Publication type:
- Article
A128: Hierarchical Clustering Methodology for Exploration of Proteomic Profile in Tears: Seeking for Markers of Uveitis Associated With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S168, doi. 10.1002/art.38549
- By:
- Publication type:
- Article
Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 5, p. 1503, doi. 10.3390/biomedicines11051503
- By:
- Publication type:
- Article